Molecular neurobiology of Alzheimer's disease (syndrome?)

Harvard Review of Psychiatry

Volumn 5, Issue 4, 1997, Pages 177-213

  Zubenko, George S ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; 4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID RECEPTOR; ACETYLCHOLINE; ALUMINUM; AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; CORTICOSTEROID; DOPAMINE; GLUTAMATE RECEPTOR; GLUTAMIC ACID; INDOMETACIN; NEUROTOXIN; NEUROTRANSMITTER; NONSTEROID ANTIINFLAMMATORY AGENT; NORADRENALIN; SEROTONIN;

ALZHEIMER DISEASE; CHOLINERGIC NERVE CELL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMENTIA; GENETIC SUSCEPTIBILITY; GLUCOSE BRAIN LEVEL; HUMAN; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; PARKINSONISM; PATHOPHYSIOLOGY; PRION DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SENILE PLAQUE;

EID: 0031413452     PISSN: 10673229     EISSN: None     Source Type: Journal    
DOI: 10.3109/10673229709000303     Document Type: Review

References (2)

1. Jorm AF, Korten AE, Henderson AS. The prevalence of dementia: a quantitative integration of the literature. Acta Psychiatr Scand 1987;76:465-79.
2. Evans DA, Funkenstein HH, Albert MS, Scherr PA, Cook NR, Chown MJ, et al. Prevalence of Alzheimer's disease in a community population of older persons: higher than previously reported. JAMA 1989;262:2551-6.